D'ALIBERTI DEBORAH

Ruolo:
Tecnica – amministrativa

Pubblicazioni

  • Barone, C., Quattrini, G., Muratore, A., Anselmi, G., Park, Y., Mehmood, N., et al. (2026). Fetal-restricted hematopoietic progenitors arise from hemogenic endothelium in vitelline and umbilical arteries. NATURE CARDIOVASCULAR RESEARCH [10.1038/s44161-026-00793-8]. Dettaglio

  • Ducci, G., Ciufolini, G., Campioni, G., Pasquale, V., Gigliotti, G., Ponzetto, S., et al. (2026). FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approach. COMMUNICATIONS BIOLOGY [10.1038/s42003-026-10356-z]. Dettaglio

  • Castoldi, G., Mauri, M., D’Aliberti, D., Spinelli, S., Testa, L., Gaverina, F., et al. (2025). Transcriptomic Profile of Human Osteoblast-like Cells Grown on Trabecular Titanium. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(8) [10.3390/ijms26083598]. Dettaglio

  • Villa, M., Geeta, G., Malighetti, F., Mauri, M., Arosio, G., Cordani, N., et al. (2024). Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma. BRITISH JOURNAL OF CANCER, 131(11), 1781-1795 [10.1038/s41416-024-02881-7]. Dettaglio

  • Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD, 143(14), 1399-1413 [10.1182/blood.2023021349]. Dettaglio